Are expensive vaccines the best investment in low-income and middle-income countries?

Lone Simonsen^*, Maarten van Wijhe, Robert Jackson Taylor

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Original language	English
Journal	The Lancet Global Health
Volume	7
Issue number	5
Pages (from-to)	e548-e549
ISSN	2214-109X
DOIs	https://doi.org/10.1016/S2214-109X(19)30040-3
Publication status	Published - 1 May 2019

Link to document

10.1016/S2214-109X(19)30040-3Licence: CC BY

Are expensive vaccines the best investment in low-income and middle-income countries?Final published version, 66.4 KBLicence: CC BY

Cite this

@article{5070d0962ed04cea8dfbf181063ebb92,

title = "Are expensive vaccines the best investment in low-income and middle-income countries?",

author = "Lone Simonsen and {van Wijhe}, Maarten and Taylor, {Robert Jackson}",

year = "2019",

month = may,

day = "1",

doi = "10.1016/S2214-109X(19)30040-3",

language = "English",

volume = "7",

pages = "e548--e549",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "The Lancet Publishing Group",

number = "5",

}

TY - JOUR

T1 - Are expensive vaccines the best investment in low-income and middle-income countries?

AU - Simonsen, Lone

AU - van Wijhe, Maarten

AU - Taylor, Robert Jackson

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1016/S2214-109X(19)30040-3

DO - 10.1016/S2214-109X(19)30040-3

M3 - Comment/debate

SN - 2214-109X

VL - 7

SP - e548-e549

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 5

ER -